Viewing StudyNCT00130702



Ignite Creation Date: 2024-05-05 @ 11:48 AM
Last Modification Date: 2024-10-26 @ 9:13 AM
Study NCT ID: NCT00130702
Status: COMPLETED
Last Update Posted: 2014-05-01
First Post: 2005-08-15

Brief Title: Study of Iressa in Patients With Relapsed or Refractory Acute Myelogenous Leukemia
Sponsor: Dana-Farber Cancer Institute
Organization: Dana-Farber Cancer Institute

Conditions & Keywords Data

Conditions:
Name
Myelogenous Leukemia Acute
Keywords:
Name View
Iressa View
AML View
acute myelogenous leukemia View
gefitinib View